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MODULATORY ACTIVITY OF ANTIOXIDANTS AGAINST THE TOXICITY OF RIFAMPICIN in vivo
Olufunsho AWODELE(1), Alade AKINTONWA(1), Vincent O. OSUNKALU(2) & Herbert A.B. COKER(3) 
SUMMARY
The World Health Organization (WHO) has shown concern about the burden of tuberculosis in the developing countries. Even 
though rifampicin is an effective drug in the management of tuberculosis, it has been documented to have some toxic effects in 
humans. Therefore, this study intends to investigate the modulatory effect of vitamins C and E on the hepatotoxicity, sperm quality 
and brain toxicity of Rifampicin.
Forty Wistar albino rats were used, 10 animals per group. Group 1 animals received 0.3 mL of distilled water, the Group 2 animals 
received the therapeutic dose of rifampicin, Group 3 animals received therapeutic doses of rifampicin plus vitamin E, while Group 4 
received therapeutic doses of rifampicin and vitamin C. The administration was performed orally during three months; the animals 
were sacrificed by cervical dislocation at the end of that period. Blood samples were collected and liver function and lipid profile 
was analyzed using fully automated clinical chemistry device. The liver, brain and reproductive organs underwent histopathological 
examination. Sperm samples were collected from the epididymis to achieve count and motility and morphological analysis. 
Results showed rifampicin alone to raise (p < 0.05) liver function enzymes (Aspartate amino transferase [AST], Serum alanine 
amino transferase [ALT] and Total Bilirubin) when compared with controls. While the vitamin E treated group showed remarkable 
protection, the vitamin C treated group showed questionable protection against the rifampicin induced liver damage. Sperm count 
results showed an important (p < 0.05) increase in the sperm quality in vitamin E and C treated groups. However, the vitamin E 
plus Rifampicin treated group showed increased lipid peroxidation. The histopathological findings revealed structural damages by 
rifampicin in liver, brain and epididymis while some remarkable architectural integrity was observed in the antioxidant-treated groups. 
It can be concluded that vitamin E or C improved sperm quality and protected against the brain damage caused by rifampicin. 
Moreover, vitamin E demonstrated remarkable hepatoprotection against rifampicin induced damage while vitamin C shows a 
questionable hepatoprotection.
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INTRODUCTION
Reduction of disease burden is one of the main targets of the 
millennium development goals. Tuberculosis has been known to represent a 
great burden in the developing countries. Thus, rifampicin is a widely used 
antimicrobial agent, which is a crucial component in treatment regimens 
for tuberculosis and has been in use since the early 1970’s (REKHA et 
al., 2005). It has also been employed in the treatment of non-tuberculosis 
infections, especially serious Staphylococcal infections (KATZ & LOR, 
1986). The World Health Organization (WHO) has recently revised 
the treatment guidelines for National Tuberculosis Programmes and 
encouraged the use of fixed dose combination drugs (WHO, 1997).
Despite the inevitable use of rifampicin in the management of 
tuberculosis, it has been reported by many researchers to have several 
toxicological effects. The works of SARASWAT et al., 1997, KATZ & 
LOR, 1986, REKHA et al., 2005, GABOW et al., 1976, have reported 
the hepatic and renal toxicity of rifampicin. More so, ATTIA, 2007, 
DHULEY & NAIK, 1998, and SADRIEH & SNYDERWINE, 1995 
have reported the mutagenic potential of rifampicin. The study of 
MINDERMANN et al., 1998 also reported the potential of rifampicin 
to cross the blood brain barrier and have a high concentration in the 
Staphylococcal and Streptococcal brain infections. It has also been 
found to increase lipid peroxidation activity in the liver and bone marrow 
(DHULEY & NAIK,1998). However, antioxidants have been known 
to scavenge free radicals which are often produced by the activities of 
some drugs; free radicals are known to cause damage to cells, tissues 
and human organs. Thus, scavenging free radicals may prevent adverse 
destruction of the architecture and functions of the body components.
Therefore, this present study intends to use an in vivo method to 
determine the toxicity of rifampicin and the modulatory activity of the 
antioxidants (vitamin C or E) against rifampicin induced hepatotoxicity, 
sperm quality and meningeal congestion.
METHODOLOGY
Forty rats (10 per group) were randomly allotted to four groups, 
consisting of the control, the rifampicin treated group, the rifampicin plus 
vitamin E treated group and the rifampicin plus vitamin C treated group. 
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Therapeutic doses of rifampicin (9 mg/kg/day), vitamin E (5 mg/kg) and 
vitamin C (8 mg/kg) were administered to the animals. The doses were 
administered via oral gavage, daily over 90 days. Rats in different groups 
were observed closely, looking for any behavioral change, feeding and 
drinking habits, as well as body weight and general morphological changes. 
After 90 days, rats were sacrificed for internal macroscopic and histological 
examination of the organs, sperm analysis and biochemical investigations. 
Liver enzymes and total bilirubin, known to be important markers in liver 
damage (ALT and AST) and lipid profile were estimated using fully an 
automated clinical chemistry analyzer (Hitachi 912, Boehringer Mannheim, 
Germany). The sperm count, motility and morphological aberrations were 
determined using the methods of MORAKINYO et al., 2008.
Results are presented as mean ± S.E.M. Statistical significance 
between the control groups and the test groups were analyzed by means 
of student t-test. P values less than 0.05 were considered significant.
RESULTS
Table 1 shows rifampicin alone to significantly (p < 0.05) increase the 
level of AST, ALT and total bilirubin when compared with the control. 
Rifampicin alone also resulted in a low, non-significant (p > 0.05) increase 
in the level of HDL, LDL and cholesterol when compared with the control. 
The co-administration of rifampicin and Vitamin E showed a significant (p 
< 0.05) decrease in the levels of AST (400.83 ± 10.48 in rifampicin alone 
and 310.2 ± 6.75 rifampicin plus Vitamin E) and small, non-significant 
decrease in the level of ALT (143.96 ± 2.59 in rifampicin alone and 142.0 
± 2.04 in rifampicin plus vitamin E). A significantly (p < 0.05) decreased 
level of bilirubin was observed in rifampicin plus vitamin E treated group 
when compared to rifampicin alone. The results showed rifampicin plus 
vitamin E treated group to significantly (p < 0.05) increase the level of 
HDL when compared with rifampicin alone and the control group. There 
was also non-significant increase in the level of LDL and cholesterol in the 
rifampicin plus Vitamin E treated group when compared with the control 
and rifampicin alone treated groups. Results obtained with the rifampicin 
plus vitamin C treated group showed a significant decreased (p < 0.05) 
in the level of bilirubin when compared with the rifampicin alone treated 
group. The results also showed a small, non-significant (p > 0.05) decrease 
in the level of ALT (141.33 ± 4.36) when compared with the rifampicin 
alone. There was no difference in the values of HDL (0.8 ± 0.0) and LDL 
(0.3 ± 0.1) from rifampicin alone treated group. 
Figures 1A and B showed the effect of rifampicin alone, rifampicin 
plus vitamin E and rifampicin plus vitamin C in the motility and abnormal 
morphology of rats’ sperm. The results showed rifampicin to significantly (p 
< 0.05) decrease the sperm motility when compared to control group. The 
vitamin E and C treated group showed a significant (p < 0.05) improvement 
in the sperm motility when compared with the single rifampicin treated group.
Moreover, the morphology results demonstrated that rifampicin 
adversely affects the sperm quality leading to a significant (p < 0.05) 
increase in the abnormality percentage of the samples when compared 
with the control group. However, the vitamin E or C treated group showed 
a significant (p < 0.05) decrease in the percentage abnormality when 
compared with the rifampicin treated group.
Figure 2 shows that rifampicin significantly (p < 0.05) decreases the 
sperm count when compared with the control group. However, the co-
administration of vitamin E or C showed a significant (p < 0.05) increase 
in the sperm count when compared to the rifampicin alone treated group.
Figure 3 shows micrograph 3A, C, & D, normal brain without 
Table 1 
Blood chemistry parameters of rats after 90-day sub chronic treatment with rifampicin and rifampicin plus vitamin E or C
Treatment 
Group (n = 10 ) 
AST 
 (U/L) 
Total 
Bilirubin
ALT 
 (U/L) 
HDL 
mg/100 mL 
LDL 
mg/100 mL 
CHOL
mg/100 mL
 (Mg/L)
Control 229.0 ± 3.0 2.96 ± 0.06 66.0 ± 1.0 0.7 ± 0.07 0.2 ± 0.02 1.37 ± 0.02
Rifampicin alone 400.83 ± 10.48a 6.26 ± 1.11a 143.96 ± 2.59a 0.8 ± 0.1 0.3 ± 0.1 1.47 ± 0.32
Rifampicin plus Vit. E 310.2 ± 6.75ab 3.14 ± 0.27b 142.0 ± 2.04a 1.06 ± 0.05ab 0.4 ± 0.2 1.54 ± 0.11a
Rifampicin plus Vit. C 400.90 ± 54.88a 4.09 ± 0.89b 141.33 ± 4.36a 0.8 ± 0 0.3 ± 0.1 1.21 ± 0.05a
Serum alanine amino transferase (ALT), Aspartate amino transferase (AST), High density lipoprotein (HDL), Low density lipoprotein (LDH), Cholesterol (CHOL). 
a: p < 0.05 in comparison with the control group; b: p < 0.05 in comparison with rifampicin group; n: number of animals per group.
Fig. 1A - Modulatory activity of vitamin E or C on the caudal epididymis sperm motility in 
rifampicin treated rats. a: p ≤ 0.05 compare with control; b: p ≤ 0.05 compare with rifampicin. 
Fig. 1B - Modulatory activity of vitamin E or C on the caudal epididymis sperm morphology in 
rifampicin treated rats. a: p ≤ 0.05 compare with control; b: p ≤ 0.05 compare with rifampicin.
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meningeal congestion. Micrograph 3B shows congestion of the meninges.
Figure 4 shows in micrographs 4A, C & D normal epididymis images, 
with the epididymis lumen filled with sperm cells. Micrograph 4B shows 
the epididymis with a reduced number of sperm cells into the lumen.
DISCUSSION
The results showed rifampicin alone to significantly (p < 0.05) 
increase the level of AST, ALT and total bilirubin, which corroborates 
the data of the study of REKHA et al., 2005. The results of the 
histopathological examination (data not shown) also showed remarkable 
damage to the architecture of the liver cells. This is an indication that 
rifampicin is toxic to the liver and it is in agreement with the earlier 
reports of SARASWAT et al., 1997 that showed that rifampicin induces 
hepatic damage and increase total bilirubin by reducing the bile flow 
as well as its content. A significant (p < 0.05) decrease in sperm count, 
motility and increased in sperm morphological abnormality were found 
in the rifampicin treated group when compared with the control group. 
This may be correlated with the previous reports of NOCKE-FIUCK 
& BREYER, 1981 and CASTELLANOS & HERNANDEZ, 1975 that 
showed rifampicin to act on the 17 alpha hydroxylaxin in the microsomal 
fraction of rat testes. Rifampicin also produced a small, non-significant 
rise in the levels of HDL, LDL and cholesterol when compared with the 
control. This may be consistent with the work of DHULEY AND NAIK, 
1998 that showed rifampicin to cause an increase in lipid peroxidation.
The co-administration of rifampicin and vitamin E showed a 
significant (p < 0.05) decrease in the levels of AST and a small, non-
significant decrease in ALT levels. Moreover, a significant (p < 0.05) 
decrease in the level of bilirubin was observed in the rifampicin plus 
vitamin E treated group. These effects may be linked to the ability of the 
antioxidant to scavenge free radicals (OAKELY, 1998). 
The results further showed rifampicin plus the vitamin E treated 
group, to significantly (p < 0.05) increase the level of HDL when 
compared with the rifampicin alone group. There was also a small, non-
significant increase in the level of LDL and cholesterol in the rifampicin 
plus vitamin E treated group. This may be due to pro-oxidant effect of 
some antioxidants (DUARTE & LUNEC, 2005). 
The results obtained with the rifampicin plus vitamin C treated 
group showed a significant decrease (p < 0.05) in the level of bilirubin 
when compared with the rifampicin treated group alone. It also showed a 
small, non-significant decrease in the level of ALT (141.33 ± 4.36) when 
compared with the rifampicin alone group. There was no difference in 
the values of HDL (0.8 ± 0.0) and LDL (0.3 ± 0.1) from the Rifampicin 
alone group. The lack of effect of vitamin C on the lipid profile when 
compared with rifampicin alone may be due to its more antioxidant 
properties than prooxidant effect (VALKON et al., 2005). 
This study also showed that vitamin E or C treated groups significantly 
(p < 0.05) improved the sperm count and motility, and also reduced the 
morphological abnormality of sperm cells. The histopathological findings 
corroborated the protection of vitamin C or E against the damage caused 
Fig. 2 - Modulatory activity of vitamin E or C on the caudal epididymis sperm count in 
rifampicin treated rats. a: p ≤ 0.05 compare with control; b: p ≤ 0.05 compare with rifampicin. 
Fig. 3 - The micrographs of the brain sections obtained from untreated and treated rats with 
rifampicin and rifampicin plus vitamin C or E. Magnification x 40. A: control (untreated 
rat); B: rat treated with rifampicin alone; C: rat treated with rifampicin plus vitamin E; D: 
rat treated with rifampicin plus vitamin C.
Fig. 4 - The micrographs of the epididymis sections obtained from rats untreated and rats 
treated with rifampicin and rifampicin plus vitamin C or E. Magnification x 40. A: control 
(untreated rat); B: rat treated with rifampicin alone; C: rat treated with rifampicin plus vitamin 
E; D: rat treated with rifampicin plus vitamin C.
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by rifampicin to the epididymis. Thus, the previous studies of WANG 
et al., 2007 and ROMAN, 2006 have shown that antioxidants preserve 
the semen quality and are beneficial in sperm function and qualities. 
Rifampicin is able to penetrate the blood brain barrier and caused 
congestion of the meninges as shown in the histopathological findings 
presented in this study. However, the co-administration of rifampicin and 
vitamin C or E showed protection of the brain against the damage caused 
by rifampicin alone. This protective effect may be due to the antioxidant 
properties of vitamins C and E, which can scavenge the free radicals that 
could cause brain cells damage.
CONCLUSION
This study has shown that vitamin E and C improved sperm quality 
and protected the meninges against rifampicin toxicity. Vitamin E also 
demonstrated remarkable protection against rifampicin induced hepatic 
damage. However, vitamin C hepatoprotective effect against rifampicin-
mediated hepatic damage is questionable. 
LIMITATION
This present study did not measure the lipid peroxidation, neither in 
liver nor in serum. Thus, further study in this area should incorporate the 
determination of lipid peroxidation in the liver, serum and spermatozoa, 
so as to establish the level of oxidative damage.
RESUMO
Atividade modulatória de anti-oxidantes contra a toxicidade da 
rifampicina in vivo
A Organização Mundial da Saúde tem mostrado preocupação acerca da 
eclosão da tuberculose nos países em desenvolvimento. Embora a rifampicina 
seja droga efetiva para o controle da tuberculose têm sido documentados seus 
efeitos tóxicos em pacientes. Portanto este estudo tem a intenção de investigar 
o efeito modulador das vitaminas C e E na hepatotoxicidade, qualidade de 
esperma e a toxicidade cerebral da rifampicina. 
Quarenta ratos albinos da raça Wistar foram usados, 10 animais por 
grupo. O grupo 1 de animais recebeu 0,3 mL de água destilada. O grupo 
2 recebeu a dose terapêutica de rifampicina. O grupo 3 recebeu doses 
terapêuticas de rifampicina mais vitamina E, enquanto o grupo 4 recebeu 
doses terapêuticas de rifampicina e vitamina C. A administração foi feita por 
via oral durante três meses; os animais foram sacrificados por deslocação 
cervical após este período. Amostras sanguíneas foram coletadas e função 
hepática e o perfil lipídico foram analisados usando aparelho automático 
de química clínica. O fígado, o cérebro e os órgãos reprodutivos foram 
submetidos a análise histopatológica. As amostras de esperma foram 
coletadas do epidídimo para contagem, motilidade e análise morfológica.  
Resultados revelaram que a rifampicina isoladamente aumenta (p < 0,05) 
os enzimas de função hepática (aspartato amino transferase {AST], alanino 
amino transferase sérica [ALT] e bilirrubina total) quando comparados com 
os controles.  Embora o grupo tratado com vitamina E mostrasse marcada 
proteção, o grupo tratado com vitamina C mostrou proteção questionável 
contra a lesão hepática induzida pela rifampicina.  Resultados da contagem 
espermática mostraram importante (p < 0,05) aumento na qualidade do 
esperma no grupo tratado com vitamina E e C. Entretanto, o grupo tratado 
com vitamina E e rifampicina mostrou aumento da peroxidação lipídica. Os 
achados histopatológicos revelaram danos estruturais pela rifampicina ao 
fígado, cérebro e epidídimo enquanto uma notável integridade arquitetural 
foi observada no grupo tratado por anti-oxidantes.
Pode-se concluir que as vitaminas E e C melhoraram a qualidade 
do esperma e protegeram o cérebro de danos causados pela rifampicina. 
Mais ainda, a vitamina E demonstrou notável hépato-proteção contra o 
dano induzido pela rifampicina enquanto a vitamina C mostrou hépato-
proteção questionável.
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